FiteBac Dental, manufacturer of patented antimicrobial compounds and additives for dentistry and medicine, has partnered with RDAbbott, a materials science and distribution company devoted to the advancement of rubber technologies; and NovationSi, the manufacturing subsidiary of RDAbbott. Together, they have synergised the effectiveness of FiteBac’s non-leaching, durable, and persistent bactericidal, fungicidal, and virucidal technology in synthetic and silicone polymer systems for revolutionary medical and dental devices.
Over the past 10 years, FiteBac founder Dr Kirk Kimmerling, and a team of over 30 scientists and dental researchers, have brought FiteBac Technology to the forefront of antimicrobial dentistry. During this time, FiteBac’s team has been cited in dozens of scientific publications, received multiple Composition of Matter patents for its revolutionary K18 and K21 antimicrobial molecules, and successfully launched multiple FDA-cleared, antimicrobial dental devices.
This global FiteBac initiative continues to grow as more scientists from universities and industries throughout the world create advanced and diverse applications, such as composites, coatings, textiles, and pharmaceuticals. FiteBac’s collaborative partnership with RDAbbott and NovationSi is a testament of this growth.
“The collective efforts from RDAbbott’s and NovationSi’s team of rubber technologists and materials scientists discovered proprietary ways to bring FiteBac Technology to efficiently enhance the antimicrobial properties of silicone elastomers,” shared Rick Ziebell, vice-president of Technology at RDAbbott. “Employing FiteBac in this manner has shown to decrease biofilm formation on the surface of a cured silicone elastomer and can enhance silicone’s use as a medical device.”
“By combining FiteBac’s revolutionary antimicrobial technology with RDAbbott’s and NovationSi’s elastomers expertise, we’re poised to bring more life-changing antimicrobial products to market in short order,” said Dr Kimmerling.
Custom third-stream additives for liquid silicone rubber (LSR) with FiteBac’s patented antimicrobial compounds incorporated will be sold by NovationSi under its NovaSperse® brand in the United States. Custom compounds for high consistency rubber (HCR) with FiteBac’s patented antimicrobial compounds incorporated will be sold by NovationSi under its PURmix® brand in the United States.